ID | 蛋白ID | Accession | GN:Name | DE:Name | GeneID |
278052 | NMD3B_RAT | Q8VHN2 | Grin3b | Glutamate receptor ionotropic, NMDA 3B; GluN3B; N-methyl-D-aspartate receptor subtype 3B; NMDAR3B; NR3B | 170796 |
278051 | NMD3B_MOUSE | Q8VHV0; Q91ZU9 | Grin3b | Glutamate receptor ionotropic, NMDA 3B; GluN3B; N-methyl-D-aspartate receptor subunit NR3B; NMDAR3B; NR3B; NMDA receptor 4; Nr4 | 170483 |
278050 | NMD3B_HUMAN | O60391; Q5EAK7; Q7RTW9 | GRIN3B | Glutamate receptor ionotropic, NMDA 3B; GluN3B; N-methyl-D-aspartate receptor subtype 3B; NMDAR3B; NR3B | 116444 |
278049 | NMD3A_RAT | O09098; O09155; Q62800; Q63268; Q9R1M7; Q9Z2H0 | Grin3a | Glutamate receptor ionotropic, NMDA 3A; GluN3A; Glutamate receptor chi-1; N-methyl-D-aspartate receptor; N-methyl-D-aspartate receptor subtype 3A; NMDAR3A; NR3A; NMDAR-L; NMDAR-L1 | 191573 |
278048 | NMD3A_MOUSE | A2AIR4; A2AIR5; Q69Z52 | Grin3a | Glutamate receptor ionotropic, NMDA 3A; GluN3A; N-methyl-D-aspartate receptor; N-methyl-D-aspartate receptor subtype 3A; NMDAR3A; NR3A; NMDAR-L | 242443 |
278047 | NMD3A_HUMAN | B3DLF9; Q5VTR3; Q8TCU5; Q8TF29; Q8WXI6 | GRIN3A | Glutamate receptor ionotropic, NMDA 3A; GluN3A; N-methyl-D-aspartate receptor subtype 3A; NMDAR3A; NR3A; NMDAR-L | 116443 |
278046 | NMD2_YEAST | D3DL27; P38798 | NMD2 | Nonsense-mediated mRNA decay protein 2; Up-frameshift suppressor 2 | 856476 |
278045 | NMD2_SCHPO | O13824 | upf2 | Nonsense-mediated mRNA decay protein 2; Up-frameshift suppressor 2 | 2542147 |
278044 | NMCR_ENTCL | P52676 | nmcR | Carbapenem-hydrolyzing beta-lactamase transcriptional activator | 0 |
278043 | NMCPB_ORYSJ | A0A0P0V8N9; Q0JJ05; Q8LIX8 | NMCP1B {ECO:0000303|PubMed:15659629} | Nuclear matrix constituent protein 1b {ECO:0000303|PubMed:15659629}; OsNMCP1b {ECO:0000303|PubMed:15659629}; Nuclear matrix constituent protein 1 {ECO:0000303|PubMed:32129897}; OsNMCP1 {ECO:0000303|PubMed:32129897} | 4325497 |
278042 | NMCPA_ORYSJ | A0A0P0VNU0; Q0DY81; Q7XXP7 | NMCP1A {ECO:0000303|PubMed:15659629} | Nuclear matrix constituent protein 1a {ECO:0000303|PubMed:15659629}; OsNMCP1a {ECO:0000303|PubMed:15659629} | 4330487 |
278041 | NMCP1_DAUCS | A0A166B1A6; O04390 | NMCP1 {ECO:0000303|PubMed:9141634} | Nuclear matrix constituent protein 1 {ECO:0000303|PubMed:9141634} | 0 |
278040 | NMCP1_ALLCE | I0J0E7 | NMCP1 {ECO:0000303|PubMed:23378381} | Nuclear matrix constituent protein 1 {ECO:0000303|PubMed:23378381}; AcNMCP1 {ECO:0000303|PubMed:23378381} | 0 |
278039 | NMB_XENLA | P43443 | nmb | Neuromedin-B | 378672 |
278038 | NMB_PIG | A0A4X1UK00; P01297 | NMB | Neuromedin-B | 100141313 |
278037 | NMB_MOUSE | Q9CR53 | Nmb | Neuromedin-B | 68039 |
278036 | NMB_HUMAN | P08949; Q96A06; Q96HH5 | NMB | Neuromedin-B | 4828 |
278035 | NMB_BOVIN | Q2T9U8 | NMB | Neuromedin-B | 506584 |
278034 | NMBR_RAT | P24053 | Nmbr | Neuromedin-B receptor; NMB-R; Neuromedin-B-preferring bombesin receptor | 25264 |
278033 | NMBR_PIG | A0A287BJR5; B2ZI34 | NMBR {ECO:0000312|VGNC:VGNC:90789} | Neuromedin-B receptor {ECO:0000312|EMBL:ACD50931.1}; NMB-R {ECO:0000305}; Neuromedin-B-preferring bombesin receptor {ECO:0000305} | 100169653 |
278032 | NMBR_MOUSE | O54799 | Nmbr | Neuromedin-B receptor; NMB-R; Neuromedin-B-preferring bombesin receptor | 18101 |
278031 | NMBR_HUMAN | E9KL38; P28336; Q5VUK8 | NMBR | Neuromedin-B receptor; NMB-R; Epididymis tissue protein Li 185a; Neuromedin-B-preferring bombesin receptor | 4829 |
278030 | NMAT4_ARATH | Q9CA78 | NMAT4 {ECO:0000303|PubMed:19946041} | Nuclear intron maturase 4, mitochondrial {ECO:0000303|PubMed:19946041}; AtnMat4 {ECO:0000303|PubMed:19946041}; 3.1.-.-; Nuclear intron maturase 2 b {ECO:0000303|PubMed:12527773}; AtnMat2b {ECO:0000303|PubMed:12527773} | 843776 |
278029 | NMAT3_ARATH | F4KI46; Q9LZA5 | NMAT3 {ECO:0000303|PubMed:19946041} | Nuclear intron maturase 3, mitochondrial {ECO:0000303|PubMed:19946041}; AtnMat3 {ECO:0000303|PubMed:19946041}; 3.1.-.-; Nuclear intron maturase 2 a {ECO:0000303|PubMed:12527773}; AtnMat2a {ECO:0000303|PubMed:12527773} | 830284 |
278028 | NMAT2_ARATH | Q94JV3; Q9FJR9 | NMAT2 {ECO:0000303|PubMed:19946041} | Nuclear intron maturase 2, mitochondrial {ECO:0000303|PubMed:19946041}; AtnMat2 {ECO:0000303|PubMed:19946041}; 3.1.-.-; Nuclear intron maturase 1 b {ECO:0000303|PubMed:12527773}; AtnMat1b {ECO:0000303|PubMed:12527773} | 834738 |
278027 | NMAT1_ARATH | Q9C8R8 | NMAT1 {ECO:0000303|PubMed:19946041} | Nuclear intron maturase 1, mitochondrial {ECO:0000303|PubMed:19946041}; AtnMat1 {ECO:0000303|PubMed:19946041}; 3.1.-.-; Nuclear intron maturase 1 a {ECO:0000303|PubMed:12527773}; AtnMat1a {ECO:0000303|PubMed:12527773}; Protein CHANGED SENSITIVITY TO CELLULOSE SYNTHESIS INHIBITORS 1 {ECO:0000303|PubMed:16621844} | 839880 |
278026 | NMAH_SCHPO | Q9UT53 | | Nicotinamide/nicotinic acid mononucleotide adenylyltransferase {ECO:0000250|UniProtKB:Q06178}; NMN/NaMN adenylyltransferase {ECO:0000250|UniProtKB:Q06178}; 2.7.7.1 {ECO:0000250|UniProtKB:Q06178}; 2.7.7.18 {ECO:0000250|UniProtKB:Q06178}; Nicotinamide-nucleotide adenylyltransferase {ECO:0000250|UniProtKB:Q06178}; NMN adenylyltransferase {ECO:0000250|UniProtKB:Q06178}; NMNAT {ECO:0000250|UniProtKB:Q06178}; Nicotinate-nucleotide adenylyltransferase {ECO:0000250|UniProtKB:Q06178}; NaMN adenylyltransferase {ECO:0000250|UniProtKB:Q06178}; NaMNAT {ECO:0000250|UniProtKB:Q06178} | 2543055 |
278025 | NMAD1_CAEEL | Q8MNT8; Q8MNT9 | nmad-1 {ECO:0000303|PubMed:25936839, ECO:0000312|WormBase:F09F7.7a} | DNA N6-methyl adenine demethylase {ECO:0000305}; 1.14.11.51 {ECO:0000305|PubMed:25936839}; N6-methyl adenine demethylase 1 {ECO:0000303|PubMed:25936839} | 175765 |
278024 | NMA2_YEAST | D6VUE7; P53204 | NMA2 {ECO:0000303|PubMed:11884393} | Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2 {ECO:0000305}; NMN/NaMN adenylyltransferase 2; 2.7.7.1 {ECO:0000269|PubMed:12597897}; 2.7.7.18 {ECO:0000305|PubMed:11884393}; NAD(+) diphosphorylase 2; NAD(+) pyrophosphorylase 2; Nicotinamide-nucleotide adenylyltransferase 2 {ECO:0000303|PubMed:12597897}; NMN adenylyltransferase 2; NMNAT 2; Nicotinate-nucleotide adenylyltransferase 2 {ECO:0000303|PubMed:11884393}; NaMN adenylyltransferase 2; NaMNAT 2 | 852893 |
278023 | NMA1_YEAST | D6VYX0; Q06178 | NMA1 {ECO:0000303|PubMed:11884393} | Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 {ECO:0000305}; NMN/NaMN adenylyltransferase 1; 2.7.7.1 {ECO:0000269|PubMed:10428462, ECO:0000269|PubMed:4291828}; 2.7.7.18 {ECO:0000305|PubMed:11884393}; NAD(+) diphosphorylase 1 {ECO:0000303|PubMed:4291828}; NAD(+) pyrophosphorylase 1 {ECO:0000303|PubMed:4291828}; Nicotinamide-nucleotide adenylyltransferase 1 {ECO:0000303|PubMed:3013296}; NMN adenylyltransferase 1; NMNAT 1; Nicotinate-nucleotide adenylyltransferase 1 {ECO:0000303|PubMed:11884393}; NaMN adenylyltransferase 1; NaMNAT 1 | 851039 |
278022 | NM111_YEAST | B0KZR3; B0KZU0; B0KZX6; B0L003; B0L021; D6W160; P53920 | NMA111 | Pro-apoptotic serine protease NMA111; 3.4.21.-; 111 kDa nuclear mediator of apoptosis | 855600 |
278021 | NM111_YEAS7 | A6ZRW1; B0KZR3 | NMA111 | Pro-apoptotic serine protease NMA111; 3.4.21.-; 111 kDa nuclear mediator of apoptosis | 0 |
278020 | NM111_YARLI | Q6BZQ9 | NMA111 | Pro-apoptotic serine protease NMA111; 3.4.21.- | 2907906 |
278019 | NM111_VANPO | A7TGI3 | NMA111 | Pro-apoptotic serine protease NMA111; 3.4.21.- | 5546890 |
278018 | NM111_PICST | A3LX99 | NMA111 | Pro-apoptotic serine protease NMA111; 3.4.21.- | 4839935 |
278017 | NM111_PICGU | A5DAL3 | NMA111 | Pro-apoptotic serine protease NMA111; 3.4.21.- | 5128985 |
278016 | NM111_PHANO | Q0UY70 | NMA111 | Pro-apoptotic serine protease NMA111; 3.4.21.- | 5970721 |
278015 | NM111_NEUCR | Q7S9D2 | nma111 | Pro-apoptotic serine protease nma111; 3.4.21.- | 3878338 |
278014 | NM111_NEOFI | A1DP85 | nma111 | Pro-apoptotic serine protease nma111; 3.4.21.- | 4585019 |
278013 | NM111_MAGO7 | A4RJH4; G4MW74 | NMA111 | Pro-apoptotic serine protease NMA111; 3.4.21.- | 2679201 |
278012 | NM111_LODEL | A5DVI0 | NMA111 | Pro-apoptotic serine protease NMA111; 3.4.21.- | 5234307 |
278011 | NM111_KLULA | Q6CIT6 | NMA111 | Pro-apoptotic serine protease NMA111; 3.4.21.- | 2895233 |
278010 | NM111_DEBHA | B5RUK4; Q6BKM0 | NMA111 | Pro-apoptotic serine protease NMA111; 3.4.21.- | 8999024 |
278009 | NM111_COCIM | J3KAD6; Q1E3N5 | NMA111 | Pro-apoptotic serine protease NMA111; 3.4.21.- | 4565254 |
278008 | NM111_CHAGB | Q2H334 | NMA111 | Pro-apoptotic serine protease NMA111; 3.4.21.- | 4392816 |
278007 | NM111_CANGA | Q6FLE2 | NMA111 | Pro-apoptotic serine protease NMA111; 3.4.21.- | 2890766 |
278006 | NM111_ASPTN | Q0CSC0 | nma111 | Pro-apoptotic serine protease nma111; 3.4.21.- | 4317596 |
278005 | NM111_ASPOR | Q2TYB1 | nma111 | Pro-apoptotic serine protease nma111; 3.4.21.- | 5999186 |
278004 | NM111_ASPNC | A5AB13 | nma111 | Pro-apoptotic serine protease nma111; 3.4.21.- | 4983185 |
278003 | NM111_ASPFU | Q4WLG1 | nma111 | Pro-apoptotic serine protease nma111; 3.4.21.- | 3508556 |